Integrum AB Class B (INTEG.B) AI Stock Analysis

• Market Cap: €180.06M
• Dividend Yield: N/A
• Average Volume (3M): 674.44K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.37
• Revenue Growth: 0.62%
• EPS Growth: -82.70%
• Country: SE
• Employees: 36
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.46
• Shares Outstanding: 20,694,328
• 10 Day Avg. Volume: 474,857
• 30 Day Avg. Volume: 674,441
• PEG Ratio: 0.01
• Price to Book (P/B): 1.64
• Price to Sales (P/S): 3.20
• P/FCF Ratio: -5.76
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: kr9.50 ▼(-7.77% Downside)

Integrum AB Class B's overall stock score is primarily influenced by its financial performance, which shows strong revenue growth but significant profitability and cash flow challenges. Technical analysis indicates a bearish trend, while valuation is weakened by a negative P/E ratio and lack of dividend yield.

Positive Factors

Business Model Strength

Integrum's recurring revenue model from software solutions and subscriptions provides a stable and predictable income stream, enhancing financial resilience.

Market Position

As a leader in healthcare software solutions, Integrum benefits from strong market positioning, which supports long-term growth and competitive advantage.

Gross Profit Margin

A high gross profit margin reflects efficient cost management and pricing power, contributing positively to long-term profitability potential.

Negative Factors

Profitability Challenges

Persistent profitability issues, with negative margins, indicate challenges in cost control and revenue generation, impacting long-term financial health.

Cash Flow Issues

Negative cash flows suggest liquidity constraints, limiting the company's ability to invest in growth opportunities and manage financial obligations.

Return on Equity

A negative return on equity indicates inefficiency in using shareholder funds to generate profits, which can deter investment and affect growth prospects.

Integrum AB Class B Business Overview & Revenue Model

Company Description

Integrum AB Class B (INTEG.B) is a leading technology company specializing in software solutions for healthcare and rehabilitation sectors. The company focuses on developing innovative digital platforms that enhance patient care and streamline workflows for healthcare providers. Integrum's core products include advanced systems for patient management, data analysis, and rehabilitation tracking, which are designed to improve outcomes and efficiency in medical practices.

How the Company Makes Money

Integrum AB generates revenue primarily through the sale of its software solutions and subscription services to healthcare institutions and rehabilitation centers. The company has a recurring revenue model, with significant income derived from annual subscriptions and licensing fees for its platforms. Additionally, Integrum may benefit from partnerships with healthcare providers and institutions that integrate its solutions into their operations, further enhancing its revenue through additional service offerings, training, and support. The company's focus on innovation and customer satisfaction also helps in retaining clients and attracting new ones, contributing positively to its financial performance.

Integrum AB Class B Financial Statement Overview

Summary

Integrum AB Class B shows strong revenue growth and a high gross profit margin. However, significant challenges in profitability and cash flow, with negative net profit and EBIT margins, and negative operating and free cash flows, weigh heavily on the financial performance.

Income Statement

Integrum AB Class B shows a mixed performance in its income statement. The TTM (Trailing-Twelve-Months) data indicates a gross profit margin of 79.06%, which is strong, but the company is struggling with profitability as evidenced by a negative net profit margin of -32.56% and a negative EBIT margin of -44.03%. Revenue growth is positive at 5.86% in the TTM, but the company has faced challenges in maintaining profitability, as seen in the negative EBITDA margin of -37.13%.

Balance Sheet

The balance sheet of Integrum AB Class B reflects a stable financial structure with a low debt-to-equity ratio of 0.026 in the TTM, indicating low leverage. However, the return on equity is negative at -18.48%, highlighting challenges in generating returns for shareholders. The equity ratio is healthy, suggesting a strong capital base relative to assets.

Cash Flow

Cash flow analysis reveals significant challenges for Integrum AB Class B. The company has a negative operating cash flow and free cash flow in the TTM, with a free cash flow growth rate of -9.06%. The operating cash flow to net income ratio is -1.45, indicating cash flow issues relative to net income. However, the free cash flow to net income ratio of 1.38 suggests some ability to cover net losses with free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	97.00M	91.10M	104.12M	74.27M	55.72M	43.09M
Gross Profit	47.05M	75.38M	91.26M	60.84M	46.56M	34.89M
EBITDA	-35.50M	-35.50M	8.76M	-20.24M	2.60M	-1.59M
Net Income	-29.89M	-30.85M	4.03M	-16.18M	21.27M	-2.14M
Balance Sheet
Total Assets	179.05M	203.25M	164.86M	165.17M	180.44M	37.21M
Cash, Cash Equivalents and Short-Term Investments	7.77M	39.60M	16.90M	41.92M	75.34M	7.66M
Total Debt	4.02M	4.84M	6.42M	7.92M	580.89K	1.54M
Total Liabilities	22.09M	25.38M	22.07M	21.64M	20.70M	12.91M
Stockholders Equity	156.95M	177.88M	142.79M	143.53M	159.74M	24.29M
Cash Flow
Free Cash Flow	-49.71M	-50.59M	-24.37M	-36.50M	-49.55M	-7.47M
Operating Cash Flow	-40.22M	-37.70M	-12.74M	-25.10M	-20.28M	-5.76M
Investing Cash Flow	-12.99M	-12.89M	-11.63M	-11.40M	-29.27M	-1.71M
Financing Cash Flow	26.84M	73.29M	-648.54K	3.08M	117.23M	2.06M

Integrum AB Class B Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 10.30
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:INTEG.B, the sentiment is Negative. The current price of 10.3 is above the 20-day moving average (MA) of 8.62, below the 50-day MA of 10.48, and below the 200-day MA of 20.31, indicating a neutral trend. The MACD of -0.74 indicates Negative momentum. The RSI at 49.17 is Neutral, neither overbought nor oversold. The STOCH value of 87.76 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:INTEG.B.

Integrum AB Class B Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CRAD.B	66 Neutral	€1.11B	47.83	6.93%	―	-5.80%	-65.99%
MNTC	52 Neutral	€264.38M	-4.33	-32.96%	―	-0.02%	-85.98%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
INTEG.B	48 Neutral	€180.06M	-5.52	-18.55%	―	0.62%	-82.70%
ACARIX	46 Neutral	€299.93M	-4.61	-102.17%	―	21.88%	48.86%
SEZI	43 Neutral	$883.55M	-6.48	-36.55%	―	62.24%	21.16%
BACTI.B	42 Neutral	€592.24M	―	-6.81%	―	-8.10%	62.08%